IOL Chemicals hits fresh all-time high in weak market; surges 20% in 3 days

In the past three months, the stock has zoomed 180 per cent as against 21 per cent rise in the benchmark S&P BSE Sensex.

Chemical sector
In the past eight trading days, the stock of the pharmaceuticals company has rallied 32 per cent
SI Reporter Mumbai
2 min read Last Updated : Jun 25 2020 | 1:54 PM IST
Shares of IOL Chemicals & Pharmaceuticals hit a new all-time high of Rs 464.65 in the intra-day trade on the BSE on Thursday, in an otherwise weak market. The stock has surged 20 per cent in the past three days on the back of heavy volumes.

As compared to the average volumes in the previous fortnight, the trading volumes on the counter jumped 1.4 times today. A combined 2.18 million shares have changed hands on the BSE and NSE till 01:11 pm. In comparison, the S&P BSE Sensex was down 0.56 per cent at 34,675 points.

In the past eight trading days, the stock of the pharmaceuticals company has rallied 32 per cent after its board, on June 17, allotted 718,000 shares at Rs 205 per share to NCVI Enterprises Limited, a promoter group company.

"The shares were allotted upon exercise of the option attached with the warrants allotted on March 30, 2019. The said shares shall remain locked-in for a period of 3 years from the date of trading approval," IOL Chemicals said in exchange filing. READ HERE

In the past three months, the stock has zoomed 180 per cent as against 21 per cent rise in the benchmark S&P BSE Sensex. IOL is one of the leading APIs/ bulk drugs company and is a significant player in the specialty chemicals space with world-class facilities. IOL has wide presence across major therapeutic categories like, pain management, anti-convulsants, anti-diabetes, anti- cholesterol and anti-platelets.

Last month, the company was recognized as a 'Three Star Export House' by the Ministry of Commerce & Industry, Government of India. This, the company said, will facilitate it to expand its product portfolio in the foreign market.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :IOL Chemicals & PharmaceuticalsBuzzing stocksMarkets

Next Story